No evidence for drug resistance by iminosugar-based HCV assembly inhibitors in tissue culture
At present, neither a selective antiviral therapy nor a vaccine is available for HCV, and the current treatment is only effective in a fraction of patients. Given the recent demonstration that antiviral compounds targeting the NS5B polymerase and the NS3/4A protease lead to rapid selection for resis...
Main Authors: | Steinmann, E, Friesland, M, Ciesek, S, Zitzmann, N, Pietschmann, T |
---|---|
格式: | Journal article |
出版: |
Elsevier
2010
|
相似書籍
-
Culture long-term treatment with iminosugars-based HCV assembly inhibitors does not lead to viral breakthrough in tissue culture
由: Steinmann, E, et al.
出版: (2011) -
Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus.
由: Steinmann, E, et al.
出版: (2007) -
Long alkylchain iminosugars block the HCV p7 ion channel
由: Pavlovic, D, et al.
出版: (2005) -
Iminosugar for treatment of tumors
由: Dwek, R, et al.
出版: (2008) -
Iminosugar antivirals: the therapeutic sweet spot
由: Alonzi, D, et al.
出版: (2017)